poptosis and oncosis are distinct forms of cell death, distinguished by both morphological and biochemical criteria. 1 The former is defined by the occurrence of internucleosomal fragmentation of genomic DNA associated with a sealed plasma membrane whereas the latter is characterized by early plasma membrane rupture and disruption of cellular organelles, including mitochondria. Myocardial ischemia and reperfusion is known to produce both myocyte apoptosis and oncosis to a variable degree. It has been demonstrated that myocyte apoptosis is a rare event during a relatively brief period (<1 h) of ischemia but is accelerated upon reperfusion. 2 However, the form of myocyte death induced by ischemia/reperfusion (I/R) is not uniform, consisting of apoptosis, oncosis, and a mixed form of apoptosis and oncosis. 3 On the other hand, the only form of myocyte death identified during reperfusion after a relatively brief period of ischemia was oncosis with DNA fragmentation. 4 Although such variability in the form of myocyte death during I/R is at least in part responsible for the lack of uniform criteria for differentiating between apoptosis and other types of cell death, it also attributes to the lack of understanding of the critical event that determines the form of myocyte death during reperfusion.
poptosis and oncosis are distinct forms of cell death, distinguished by both morphological and biochemical criteria. 1 The former is defined by the occurrence of internucleosomal fragmentation of genomic DNA associated with a sealed plasma membrane whereas the latter is characterized by early plasma membrane rupture and disruption of cellular organelles, including mitochondria. Myocardial ischemia and reperfusion is known to produce both myocyte apoptosis and oncosis to a variable degree. It has been demonstrated that myocyte apoptosis is a rare event during a relatively brief period (<1 h) of ischemia but is accelerated upon reperfusion. 2 However, the form of myocyte death induced by ischemia/reperfusion (I/R) is not uniform, consisting of apoptosis, oncosis, and a mixed form of apoptosis and oncosis. 3 On the other hand, the only form of myocyte death identified during reperfusion after a relatively brief period of ischemia was oncosis with DNA fragmentation. 4 Although such variability in the form of myocyte death during I/R is at least in part responsible for the lack of uniform criteria for differentiating between apoptosis and other types of cell death, it also attributes to the lack of understanding of the critical event that determines the form of myocyte death during reperfusion.
Myocyte oncosis is associated with loss of mitochondrial function and adenosine triphosphate (ATP). Excessive intracellular Ca 2+ is taken up by mitochondria at the expense of mitochondrial membrane potential (∆ m), leading to abrogation of oxidative phosphorylation and ATP generation via F1/F0 ATPase. 5 Excessive entry of Ca 2+ into the mitochondria in concert with oxidative stress provokes opening of the mitochondrial permeability transition (MPT) pores, which also contributes to the collapse of ∆ m and loss of mitochondrial function. 6 In contrast to oncosis, apoptosis is an energy-requiring process. The opening of MPT pores triggers cytochrome c release from the intermembrane space, 7, 8 which in the presence of Apaf-1 and ATP or dATP activates caspase-9, which in turn activates caspase-3, the executioner responsible for activation of caspase-activated DNase and the resultant DNA fragmentation specific for apoptosis. 9 Thus, depletion of cellular energy may inhibit caspase-3 activation and terminate the final degradation step of apoptosis. Several recent studies have shown that the intracellular ATP level is a critical determinant of the form of cell death. [10] [11] [12] These studies suggest that oncosis and apoptosis represent different outcomes of the same pathway induced by MPT pore opening so that in the absence of ATP, oncosis prevails whereas the presence of ATP favors and promotes apoptosis.
Unlike the plasma membranes of other cell types and isolated myocytes that do not undergo mechanical stress, the sarcolemma of myocytes in vivo is exposed to mechanical stress upon reperfusion, associated with supercontraction and re-introduction of contractile activity. The resultant disruption of the sarcolemma abrogates mitochondrial function and severely depletes the cellular energy necessary for progression of mitochondria-mediated apoptosis. Although myocytes become oncotic without reperfusion when the period of ischemia is prolonged, it has been demonstrated that the permeability of the sarcolemma is not increased in the majority of myocytes after a brief period (30-40 min) of ischemia alone. 13 Therefore, the present study was designed to test the hypothesis that mechanical stress is a critical determinant of the form of myocyte death during reperfusion.
Methods

Animal Preparation and Perfusion Technique
Male Sprague-Dawley rats weighing 250-300 g were used and all experiments were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and approved by the institutional Animal Care Committee of Kansai Medical University.
The rats were anesthetized intraperitoneally with pentobarbital sodium (100 mg/kg). After thoracotomy, the heart was rapidly excised, placed in a temperature-regulated heart chamber, and perfused at a constant mean pressure of 70-75 mmHg with Krebs-Henseleit bicarbonate (KHB) buffer solution containing the following in mmol/L: 118 NaCl, 4.7 KCl, 1.2 MgSO4, 25 NaHCO3, 1.2 KH2PO4, 1.8 CaCl2, and 11 glucose, with a pH of 7.4 at 37°C when equilibrated with a mixture of 95% O2 and 5% CO2. When the buffer contained the 2,3-butanedione monoxime (BDM: 20 mmol/L), which is known to block skeletal muscle contractility by inhibiting myosin ATPase activity, 14 an equimolar concentration of NaCl was reduced in the buffer. Hyposmotic buffer (180 mosm) was made by reducing the concentration of NaCl. This osmolarity was chosen on the basis of a previous study that demonstrated that little damage of the sarcolemma occurred using this hyposmotic buffer under normoxic perfusion, whereas massive enzyme leakage was observed with the same buffer after a period of anoxic perfusion. 15 
Measurements of Left Ventricular (LV) Function
During the stabilization period, a latex balloon was inserted into the left ventricle through the left atrium to measure the isovolumic LV function. The balloon was filled with saline solution to produce an LV end-diastolic pressure of 5-10 mmHg at baseline, and the balloon volume was kept constant throughout the experiment. Hearts with LV developed pressures less than 80 mmHg or heart rates less than 240 beats/min at baseline were excluded from the study. Experimental protocol. In the control ischemia/reperfusion (I/R) group, the hearts were subjected to 30 min normothermic global ischemia followed by reperfusion for 150 min. In the I/R 2,3-butanedione monoxime (BDM) group, BDM was administered during reperfusion for 150 min. In the BDM/withdrawal (WD) group, the last 30 min reperfusion was conducted with normal Krebs-Henseleit bicarbonate (KHB) buffer. To provide mechanical stretch in the BDM-treated hearts, the intraventricular balloon was inflated to increase left ventricular pressure to 200 mmHg for 15 s, repeated 10 times with a 15-s interval of balloon deflation (arrows). This procedure was performed at the onset of reperfusion (BDM + early stretch) or 120 min after reperfusion with BDM (BDM + late stretch). In the experiments that imposed physical stress at the time of reperfusion, the hearts were reperfused with 1 mol/L isoproterenol (Iso) or hyposmotic (HS) buffer for 10 min followed by perfusion with normal KHB buffer for 140 min. Finally, the caspase-3 inhibitor, Ac-DEVD-CHO (DEVD: 1 mol/L), was added for 10 min before ischemia and throughout reperfusion with or without BDM or BDM/ WD for the last 30 min during reperfusion. In all groups, 20 min before the end of experiments Evans blue (0.1%) or propidium iodide (20 g/ml) and tetramethylrhodamine ethylester (1 mol/L) were administered to the buffer for 15 min and excluded for 5 min to wash out the dyes.
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Experimental Protocol
The experimental protocol is shown in Fig 1. In the control I/R group, the hearts were subjected to 30 min normothermic global ischemia followed by reperfusion for 150 min. In the I/R BDM group, BDM was administered during reperfusion for 150 min. In the I/R BDM/withdrawal (WD) group, the last 30 min reperfusion occurred in normal KHB buffer. To provide mechanical stretch in the BDMtreated hearts, the intraventricular balloon was inflated to increase LV pressure to 200 mmHg for 15 s, repeated 10 times with a 15-s interval of deflation. This procedure was performed at the onset of reperfusion or 120 min after reperfusion with BDM. In another experiment that imposed mechanical stress at the time of reperfusion, the hearts were reperfused for 10 min with 1 mol/L isoproterenol to increase contractile force or hyposmotic buffer to stretch the sarcolemmal membrane by cell swelling, followed by perfusion with normal KHB buffer for 140 min. Finally, the caspase-3 inhibitor, Ac-DEVD-CHO (DEVD) (1 mol/L) was added for 10 min before ischemia and throughout reperfusion with or without BDM or BDM/WD for the last 30 min of reperfusion. In all groups, 20 min before the end of experiments Evans blue (EB: 0.1%) or propidium iodide (PI: 20 g/ml) and tetramethylrhodamine ethylester (TMRE: 0.5 mol/L) was administered to the buffer for 15 min and excluded for 5 min to wash out the dyes. EB and PI are membrane-impermeable red-fluorescence dyes that accumulate in the cells when the plasma membrane permeability increases with oncosis. TMRE is a red-fluorescence fluorophore that accumulates electrophoretically into mitochondria in response to negative ∆ m and binds to the inner mitochondrial membrane. 16 This property of TMRE allowed us to measure ∆ m in frozen sections. 17 The last LV function was measured just prior to perfusion with EB or PI and TMRE, because perfusion with EB profoundly decreased LV function in all groups.
Creatine Kinase (CK) Assay
Coronary effluent was collected at the indicated time point, and CK activity was measured as described. 18 
Infarct Size Measurement
Infarct size was measured by a triphenyltetrazolium chloride (TTC) staining method as described. 19 
Caspase-3 Activity Assay
At the indicated time point, the experiment was terminated and a ventricular muscle sample was taken and snap-frozen in liquid nitrogen. Caspase-3 activity was measured using a kit from MBL (Nagoya, Japan). Cardiac muscle lysate was prepared by homogenization of the frozen tissue sample using an ULTRA-TURLAX homogenizer in the lysis buffer provided with the kit. The lysates were centrifuged at 10,000 G for 10 min at 4°C, and the supernatants containing 100 g protein were used for caspase-3 activity assay as described previously. 20 
Terminal Deoxynucleotide Nick-End Labeling (TUNEL) and Oncosis Assay
At the end of EB or PI perfusion experiments, the heart was frozen in liquid nitrogen and the frozen sections were assayed for TUNEL using Apop Tag (Intergen, Purchase, NY, USA). Negative control slides were processed with the terminal deoxynucleotidyl transferase enzyme excluded. Double fluorescence laser microscopic images of TUNEL and EB or PI were obtained using a confocal laser microscope (Olympus, Tokyo, Japan). The number of TUNELand/or EB-or PI-positive, as well as TUNEL-and EB-or PI-negative, myocytes was counted in 60 high power fields (magnification ×600) from the endocardium through the epicardium of the mid LV free wall and the percentage of TUNEL-and/or EB-or PI-positive myocytes was calculated.
TUNEL and ∆ m Assay
At the end of TMRE and PI perfusion experiments, the heart was rapidly frozen in liquid nitrogen and the frozen sections were assayed for TUNEL as described above. TUNEL, TMRE and PI fluorescence were visualized with a confocal laser microscope. Ten myocytes that were neither TUNEL-nor PI-positive, TUNEL-positive only, PI-positive only, or both TUNEL-and PI-positive were at randomly chosen by blinded observers. The cytoplasmic fluorescence intensity of TMRE in these myocytes was standardized by the same background intensity and quantified using image analyzing software (Win Roof, Mitani Co, Fukui, Japan).
Materials
EB, BDM, isoproterenol, and PI were obtained from Sigma (Tokyo, Japan). EB and isoproterenol were dissolved in KHB buffer. TMRE was purchased from Molecular Probes (Eugene, OR, USA) and dissolved in dimethylsulfoxide (DMSO) at a final concentration of 0.01%. DEVD was obtained from Calbiochem (San Diego, CA, USA) and dissolved in DMSO at a final concentration of 0.01%.
Statistical Analysis
All numerical data are expressed as mean ± SE. Statistical analysis was performed by 1-way or 2-way repeated measures ANOVA (for LV function) followed by the Bonferroni post hoc test. The differences were considered significant at a p-value of <0.05.
Results
Predominant Form of Myocyte Death After Unmodified Reperfusion
TUNEL-or EB-positive myocytes were rarely found in the heart perfused normally for 180 min (data not shown). The heart subjected to 30 min of ischemia followed by 150 min reperfusion contained myocytes positive for TUNEL only, EB only, and both TUNEL and EB (Fig 2) . Quantitative analysis showed that TUNEL-positive only myocytes comprised 11.0±1.5% of the total number of myocytes, whereas EB-positive only and both TUNEL-and EB-positive myocytes comprised 10.0±1.1 and 24.0±1.5%, respectively. Thus, the predominant form of myocyte death after unmodified reperfusion was oncosis with DNA fragmentation.
Mitochondria in Apoptotic and Oncotic Myocytes
It is known that apoptosis is associated with loss of ∆ m, but that energy is required to accomplish the apoptotic processes. This seemingly inconsistent phenomenon in the progression of apoptosis prompted us to hypothesize that some mitochondria in apoptotic myocytes would maintain their ∆ m to generate ATP during reperfusion, whereas all mitochondria in oncotic myocytes would lose ∆ m homogeneously. To examine this possibility, we used TMRE to evaluate ∆ m in myocytes positive for TUNEL and/or PI in the heart subjected to I/R. The myocytes devoid of TUNEL or PI staining contained abundant mitochondria with intense TMRE fluorescence (Fig 3A) . However, the myocytes positive only for TUNEL contained mitochondria with inhomogeneous uptake of TMRE (Fig 3B) . In contrast, a predominant population of myocytes positive for either PI only or TUNEL and PI contained mitochondria in which TMRE fluorescence was homogeneously lost (Figs 3C,D) . Quantitative analysis showed that TMRE fluorescence density in the TUNEL-positive myocytes was significantly lower than Tetramethylrhodamine ethylester (TMRE) uptake in apoptotic and oncotic myocytes. The heart was subjected to 30 min of ischemia followed by 150 min of reperfusion. At 20 min before the end of experiments propidium iodide (PI) and TMRE was perfused for 15 min followed by washout for 5 min. The frozen sections were stained for terminal deoxynucleotide nick-end labeling (TUNEL) (green nuclei), PI (red nuclei) and TMRE (red cytoplasm) as described in the text. Bars =10 m. The cytoplasmic fluorescence intensity of TMRE was quantified as described in the text. Each bar graph represents mean ± SE of 5 experiments. *p<0.05 compared with both TUNEL-negative and PInegative myocytes, † p<0.05 compared with TUNEL-positive only myocytes, # p<0.05 compared with PI-positive only myocytes. Myocyte death during reperfusion. The heart was subjected to 30 min of ischemia followed by 150 min of reperfusion. At 20 min before the end of experiments Evans blue (EB) was perfused for 15 min followed by washout for 5 min. The frozen sections were stained for terminal deoxynucleotide nick-end labeling (TUNEL) as described in the text. Fluorescence staining of TUNEL (green nuclei) or EB (red cytoplasm) was visualized as described in the text. Bars =20 m. The number of TUNELpositive only, EB-positive only, or both TUNEL-and EB-positive myocytes was counted and the total number of these myocytes was calculated as described in the text. Each bar graph represents mean ± SE of 5 experiments.
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in TUNEL-and PI-negative myocytes but significantly higher than in PI-positive only or TUNEL-and PI-positive myocytes (Fig 3E) . However, TMRE fluorescence density in the TUNEL-and PI-positive myocytes was significantly higher than the PI-positive only myocytes.
Effect of Contractile Blockade During Reperfusion
It has been demonstrated that the use of contractile blockers at the time of reperfusion prevents myocardial oncosis, 21,22 so we investigated the effect of BDM on myocyte apoptosis and oncosis. LV developed pressure and LV+ dp/dt were decreased <10% of the baseline during reperfusion with BDM (Table 1) . LV-dp/dt showed the same trend (data not shown). LV end-diastolic pressure and heart rate were also significantly decreased during reperfusion with BDM. In the heart with unmodified reperfusion, CK release peaked at 30 min after reperfusion (Fig 4A) . Neither CK release nor infarction was observed during reperfusion with BDM ( Figs 4A,F) . However, robust CK release and infarction was induced upon WD of BDM, associated with restoration of contractile activity. Infarct size after the WD of BDM was comparable with that in the heart without BDM during reperfusion. Caspase-3 activity was not increased and TUNEL-positive myocytes did not emerge during perfusion with BDM for 3 h without ischemia (data not shown). In contrast, caspase-3 activity was significantly increased during reperfusion with BDM, compared with unmodified reperfusion, which showed the maximum increase in caspase-3 activity 15 min after reperfusion (Fig 4B) . Reperfusion with BDM produced predominantly TUNELpositive only myocytes (Fig 4C) . However, WD of BDM decreased caspase-3 activity to the level observed in the heart with unmodified reperfusion and markedly increased the population of myocytes positive for both TUNEL and EB without significantly increasing the total number of TUNEL-positive only, EB-positive only and TUNEL-and EB-positive myocytes (Fig 4D) . Oncosis size calculated by the EB staining method (Fig 4E) was similar to infarct size measured by the TTC staining method (Fig 4F) , although infarct size was somewhat greater than oncosis size in the control and the BDM-withdrawn hearts and smaller than the oncosis size in the heart treated with BDM throughout reperfusion. Thus, these results indicate that contractile arrest during reperfusion inhibits oncosis and promotes apoptosis by increasing the activity of caspase-3, whereas re-introduction of contractile force in myocytes that had already completed the apoptotic process produces oncosis with DNA fragmentation. To verify that mechanical force is indeed a trigger for myocyte oncosis in the BDM-withdrawn heart, we provided mechanical stretch in the BDM-treated heart by inflating the intraventricular balloon to increase LV pressure to 200 mmHg for 15 s repeated 10 times. This procedure did not induce CK release nor did it produce infarction in the non-ischemic heart perfused with BDM (data not shown). In contrast, the balloon inflation stretch of the heart at the onset or 120 min after reperfusion with BDM temporarily increased CK release and produced an infarction that was similar to that produced with WD of BDM ( Figs 5A,F) . The balloon inflation stretch at the onset of reperfusion inhibited an increase in caspase-3 activity early after reperfusion (Fig 5B) and increased the EB-positive only myocytes, associated with a decrease of the TUNEL-positive only myocytes ( Figs 5C,D) . In contrast, the balloon inflation stretch implemented 120 min after reperfusion decreased caspase-3 activity and increased the TUNEL-and EB-posi- 
Effect of Oncosis After Reperfusion
We further examined whether a sudden onset of oncosis upon reperfusion inhibits the apoptotic process and increases the population of myocytes with oncosis only. Administration of isoproterenol for 10 min after reperfusion significantly increased the LV developed pressure, LV+ dp/dt and heart rate, whereas hyposmotic reperfusion decreased these parameters (Table 1) . Although administration of isoproterenol or hyposmotic buffer for 10 min did not cause significant CK release from the normally perfused heart (data not shown), robust CK release was observed as early as 5 min after reperfusion with administration of isoproterenol or hyposmotic buffer (Fig 6A) . Infarct size was also significantly increased by treatment with isoproterenol or hyposmotic buffer (Fig 6F) . The increase in CK release was associated with inhibition of caspase-3 activity during reperfusion (Fig 6B) . The predominant form of myocyte death during reperfusion in these hearts was oncosis only and the number of myocytes positive for both TUNEL and EB was significantly reduced compared with the heart undergoing unmodified reperfusion (Figs 6C,D) . The total number of myocytes positive for TUNEL only, EB only and both TUNEL and EB was significantly increased compared with the heart undergoing unmodified reperfusion. Oncosis size in the isoproterenol-and hyposmotic buffer-treated hearts was similar to infarct size ( Figs 6E,F) . These results indicate that increased mechanical stress upon reperfusion produces a sudden onset of oncosis and terminates the apoptotic process during the subsequent reperfusion.
Effect of Caspase-3 Inhibitor
Finally, we examined the effect of pharmacological inhibition of caspase-3 on myocyte apoptosis and oncosis during reperfusion. Treatment with DEVD before ischemia and throughout reperfusion had no significant effect on post-ischemic recovery of LV function (Table 1) nor did it inhibit CK release and infarction (Figs 7A,F) . In addition, although treatment with DEVD significantly inhibited caspase-3 activity (Fig 7B) and reduced the number of TUNEL-positive only and both TUNEL-and EB-positive myocytes (Figs 7C,D) , the caspase-3 inhibitor increased myocytes positive for EB only without significantly affecting the total number of apoptotic, oncotic, or both forms of myocytes. When the heart was co-treated with DEVD and BDM during reperfusion, the number of EB-positive only myocytes, oncosis size and infarct size (Figs 7D-F) was also markedly reduced. However, a robust increase in EBpositive only myocytes was observed upon WD of BDM in this group of hearts, so the total number of apoptotic, oncotic, and both forms of myocytes, as well as oncosis size and infarct size, were not significantly different from those in the heart with unmodified reperfusion.
Discussion
We examined whether mechanical stress is a critical determinant of the form of myocyte death during the early phase of reperfusion. The present results suggests that increased mechanical stress at the time of reperfusion induces myocyte oncosis by disrupting the sarcolemma, which abrogates mitochondrial function and inhibits the apoptotic process during the subsequent period of reperfusion. The salient findings to support this hypothesis are (1) myocyte apoptosis was associated with partially maintained ∆ m whereas oncosis was associated with totally collapsed ∆ m, (2) blockade of contractile force by reperfusion with BDM increased caspase-3 activity and apoptotic myocytes, (3) introduction of mechanical stress after completion of the apoptotic process by WD of BDM or repeated myocardial stretch converted apoptotic myocytes to oncotic myocytes with DNA fragmentation, (4) sudden introduction of mechanical stress upon reperfusion by repeated myocardial stretch or treatment with isoproterenol or hyposmotic buffer increased CK release, abolished ∆ m and caused inhibition of caspase-3, leading to an increase in only oncotic myocytes, and (5) administration of a caspase-3 inhibitor prevented myocyte apoptosis but did not inhibit oncosis during reperfusion with normal buffer or after WD of BDM.
The sequence of events that produces myocyte apoptosis and oncosis during reperfusion has been a matter of considerable debate. Ohno et al 4 claimed that DNA fragmentation occurs in myocytes that have already shown irreversible oncotic, but not apoptotic, ultrastructures with ischemia and/or reperfusion. In their scenario, cellular damage of I/R myocytes proceeds from reversible and irreversible oncosis without DNA fragmentation to irreversible oncosis with or without DNA fragmentation. Although we did not use electron microscopic examination, which is the golden standard for diagnosing apoptosis, the results of the present study argue against the sequence of events that determine the final form of myocyte death during reperfusion as proposed by Ohno et al. 4 Our observations suggest that myocyte damage during reperfusion proceeds through activation of the mitochondria-mediated apoptotic pathway, but that accidental cell death (ie, oncosis), induced by mechanical stress, interrupts the progression apoptosis. Consequently, apoptosis is the predominant form of myocyte death when mechanical stress is weak enough to maintain sarcolemmal integrity during reperfusion, whereas the introduction of strong mechanical stress gives rise to only oncotic myocyte death when the apoptotic process is not completed. On the other hand, sarcolemmal disruption after completion of the apoptotic process produces oncotic myocytes with DNA fragmentation.
It has been proposed that myocyte apoptosis and necrosis independently contribute to myocardial infarction after a prolonged period of ischemia. 23 The present study demonstrated that treatment with BDM during reperfusion produced a greater number of only apoptotic myocytes and less oncosis than in the control-reperfused heart, as detected by EB and TTC staining. Although care must be taken to interpret the results obtained from experiments using BDM, because this agent acts as an organic phosphatase with multiple side-effects, 24 the present results suggest that contractile force is responsible for the occurrence of oncosis and that myocyte apoptosis does not contribute to infarction during the early phase of reperfusion. However, apoptotic myocytes would eventually deteriorate to secondary necrosis associated with the loss of plasma membrane integrity during the later phase of reperfusion. At this stage, these myocytes would not stain with TTC and would be detected as infarcted myocardium because the dehydrogenase enzymes responsible for the staining with TTC are lost through the leaky plasma membrane.
Oncosis size calculated by EB staining was similar to infarct size measured by TTC staining, although infarct size was somewhat greater than oncosis size in the control and BDM-withdrawn hearts and smaller than oncosis size in the hearts treated with BDM throughout reperfusion. Such a difference between the staining methods in the oncosis and infarct sizes is presumably due to inherent technical limitations in microscopic and macroscopic evaluation. Microscopic evaluation of oncosis size by the EB staining method can only identify oncotic myocytes that are dispersed between intact myocytes and may be overlooked by macroscopic evaluation of infarct size by the TTC staining method. Moreover, the validity of the EB staining method relies on uniform perfusion of myocardium. When noreflow area exists within the infarcted myocardium, EB dye does not enter oncotic myocytes and infarct size would be underestimated. In contrast, the TTC staining method may not be able to detect intact myocytes that exist focally within the area of infarcted myocardium.
We demonstrated that apoptotic myocytes contain a population of mitochondria with maintained ∆ m, whereas oncotic myocytes contain only ∆ m-collapsed mitochondria. Thus, average ∆ m was significantly higher in apoptotic myocytes than in oncotic myocytes. Of the oncotic myocytes, average ∆ m was significantly higher in simultaneously TUNEL-positive myocytes than in the oncotic only myocytes. These observations suggest that ∆ m is inversely related to the extent of sarcolemmal damage. Sarcolemmal disruption causes unlimited entry of extracellular Ca 2+ which is taken up by mitochondria in the expense of ∆ m, leading to abrogation of oxidative phosphorylation and ATP generation. Thus, it is conceivable that myocytes without sarcolemmal damage could produce greater amounts of ATP required for the accomplishment of apoptosis. Several recent studies have indeed demonstrated that the intracellular ATP level is a critical determinant of the form of cell death. [17] [18] [19] Although our study was unable to evaluate ATP levels in individual myocytes undergoing apoptosis and oncosis because of the inherent difficulty in measuring ATP in individual myocytes, Terminella et al 25 found that the critical value of ATP required for completion of apoptotic signaling was 12-50% of the normal cellular ATP concentration. Provided that the average ∆ m in individual myocytes is proportional to the intracellular ATP level, the average TMRE uptake of myocytes undergoing apoptosis (31.9±1.8% of non-ischemic myocytes) observed in the present study is consistent with such a critical ATP concentration in determining the form of cell death. Moreover, our study showed that ∆ m in apoptotic myocytes was heterogeneously didstributed among mito-chondria. It has been demonstrated that the sensitivity of mitochondria to pro-apoptotic agents and the timing of the PTP pore opening in these mitochondria are heterogeneous within individual cells. 26 The observation that certain populations of mitochondria may not depolarize at the same time as others in response to a pro-apoptotic stimulus supports the notion that some mitochondria are involved in signaling during apoptosis, whereas others maintain ∆ m and ATP production during the critical stages of apoptosis. 27 We used the TUNEL assay to determine myocyte apoptosis. TUNEL detects double-and single-stranded DNA, which is not specific for apoptotic DNA degradation induced by caspase-activated DNase 28 and therefore some non-apoptotic nuclei that show active gene transcription may be labeled by the TUNEL technique. 29 Therefore, it is possible that TUNEL assay overestimates the degree of apoptotic myocytes. Nevertheless, the fact that enhanced oncotic myocyte death was associated with both inhibition of caspase-3 activity and the appearance of TUNEL-positive myocytes precludes necrotic DNA fragmentation as a major mechanism for the increase in TUNEL-positive myocytes in our experimental model.
The present study demonstrated that the caspase-3 inhibitor DEVD prevented apoptosis but increased the number of myocytes undergoing oncosis only. When reperfusion was carried out with DEVD and BDM, both myocyte apoptosis and oncosis were prevented. However, re-introduction of contractility after switching to the normal buffer provoked massive oncosis without increasing TUNEL-positive myocytes. These observations suggest that DEVD can limit apoptotic myocyte death but not inhibit oncotic myocyte death induced by contractile force. The cardioprotective effect of caspase inhibitors is controversial. It has been demonstrated that the caspase inhibitor ZVAD-fmk reduced the number of myocytes with DNA fragmentation and infarct size in the rat heart subjected to regional I/R in vivo, 30 but the same caspase inhibitor or the structurally similar caspase inhibitors, YVAD and DEVD, failed to reduce infarct size in in-vivo I/R models in rabbit and rat hearts. 31, 32 Although the reason for such discrepant observations remains unknown, the present study raises the possibility that the efficacy of caspase inhibitors administered during reperfusion depends on restoration of sarcolemmal integrity. When sarcolemmal integrity is restored during treatment with caspase inhibitors and oncosis does not take place in myocytes spared from apoptosis, the ultimate infarct size could be reduced because inhibition of apoptosis circumvents the secondary necrosis that culminates in an infarct. However, this does not appear to be the case for DEVD used in the present study. DEVD failed to prevent oncosis in myocytes negative for TUNEL, indicating that sarcolemmal integrity was not restored in myocytes spared from apoptosis during treatment with this caspase inhibitor.
Based on the present results and those from previous studies from our laboratory, 17, 19, [33] [34] [35] the role of mechanical stress in determining the form of myocyte death during reperfusion can be delineated. Myocardial I/R predisposes to sarcolemmal fragility. When mechanical stress is inhibited during reperfusion, the sarcolemma remains intact and mitochondrial function is partially preserved, which allows generation of ATP required for activation of caspase-3 and the completion of the apoptotic process. In contrast, imposing strong mechanical stress at the time of reperfusion disrupts the sarcolemma and causes oncosis, which abrogates mitochondrial function and depletes cellular ATP, leading to inactivation of caspase-3 and termination of the apoptotic process. Introduction of mechanical stress after completion of the apoptotic process produces oncosis in conjunction with apoptotic DNA fragmentation. Caspase inhibition blocks apoptotic myocyte death but does not prevent oncosis upon imposition of mechanical stress, unless sarcolemmal integrity is restored during inhibition of the apoptotic process. Further studies are required to address the unresolved issue as to whether interruption of the mitochondria-mediated death pathway for apoptosis and restoration of sarcolemmal integrity against oncosis limits the ultimate number of dying myocytes.
